NO872463L - Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensiv virkning. - Google Patents

Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensiv virkning.

Info

Publication number
NO872463L
NO872463L NO872463A NO872463A NO872463L NO 872463 L NO872463 L NO 872463L NO 872463 A NO872463 A NO 872463A NO 872463 A NO872463 A NO 872463A NO 872463 L NO872463 L NO 872463L
Authority
NO
Norway
Prior art keywords
nitrophenyl
carbomethoxy
dimethyl
phenoxy
dihydropyridine
Prior art date
Application number
NO872463A
Other languages
English (en)
Norwegian (no)
Other versions
NO872463D0 (no
Inventor
Gilles Genain
Original Assignee
Syntex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Lab filed Critical Syntex Lab
Publication of NO872463D0 publication Critical patent/NO872463D0/no
Publication of NO872463L publication Critical patent/NO872463L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO872463A 1986-06-13 1987-06-12 Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensiv virkning. NO872463L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/874,264 US4761420A (en) 1986-06-13 1986-06-13 Antihypertensive dihydropyridine derivatives

Publications (2)

Publication Number Publication Date
NO872463D0 NO872463D0 (no) 1987-06-12
NO872463L true NO872463L (no) 1987-12-14

Family

ID=25363361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872463A NO872463L (no) 1986-06-13 1987-06-12 Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensiv virkning.

Country Status (13)

Country Link
US (1) US4761420A (de)
EP (1) EP0249245A3 (de)
JP (1) JPS632977A (de)
KR (1) KR880000394A (de)
AU (1) AU7416087A (de)
DK (1) DK300887A (de)
FI (1) FI872634A (de)
HU (1) HUT44503A (de)
IL (1) IL82860A0 (de)
NO (1) NO872463L (de)
PL (1) PL266231A1 (de)
PT (1) PT85075A (de)
ZA (1) ZA874257B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
HUT48461A (en) * 1987-12-11 1989-06-28 Syntex Lab Process for producing pharmaceutical compositions containing 1,4-dihydropyridine derivatives
DE3801717C1 (de) * 1988-01-21 1989-05-24 Alter S.A., Madrid, Es
US5100892A (en) * 1990-11-13 1992-03-31 Glaxo Inc. Dihydropyridine vasodilator agents
DE4041814A1 (de) * 1990-12-24 1992-07-02 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von dihydrophyridincarbonsaeuren
US5135936A (en) * 1991-03-05 1992-08-04 Marion Merrell Dow Inc. Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
EP0824115A1 (de) * 1996-08-13 1998-02-18 Bp Chemicals S.N.C. Polymerisationsverfahren
US7866673B2 (en) * 2007-07-20 2011-01-11 Therma Blade Hockey Corp. Heating arrangement for ice skate blades
US9416901B2 (en) 2007-07-20 2016-08-16 Scorched Ice Inc. Ice skate blade and blade heating arrangement
US7866674B2 (en) * 2007-09-07 2011-01-11 Thermablade Hockey Corp. Electrically heated ice skates
CN102655095B (zh) 2011-06-01 2014-10-15 京东方科技集团股份有限公司 薄膜晶体管及阵列基板的制造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3018259A1 (de) * 1980-05-13 1981-11-19 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
DE3567460D1 (en) * 1984-06-07 1989-02-16 Pfizer Ltd Dihydropyridines
JPS6143165A (ja) * 1984-08-07 1986-03-01 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体の製造法
US4595690A (en) * 1985-02-11 1986-06-17 Syntex (U.S.A.) Inc. Antihypertensive dihydropyridine derivatives

Also Published As

Publication number Publication date
DK300887D0 (da) 1987-06-12
JPS632977A (ja) 1988-01-07
FI872634A0 (fi) 1987-06-12
EP0249245A2 (de) 1987-12-16
ZA874257B (en) 1989-01-25
HUT44503A (en) 1988-03-28
AU7416087A (en) 1987-12-17
IL82860A0 (en) 1987-12-20
PT85075A (en) 1987-07-01
KR880000394A (ko) 1988-03-25
FI872634A (fi) 1987-12-14
DK300887A (da) 1987-12-14
NO872463D0 (no) 1987-06-12
PL266231A1 (en) 1988-09-01
US4761420A (en) 1988-08-02
EP0249245A3 (de) 1988-08-10

Similar Documents

Publication Publication Date Title
NO872463L (no) Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensiv virkning.
US4448964A (en) 1,4-Dihydropyridine derivatives
RU1831476C (ru) Способ получени производных дигидропиридина
JPH0517908B2 (de)
US4707486A (en) Diaryl piperidine containing esters of 1,4-dihydropyridines and coronary therapeutic use
EP0804431A1 (de) Glycoprotein iib/iiia-antagonisten
BG62331B1 (bg) Бензопиран и съответстващи му левкотриен в4 антагонисти
JP2006348034A (ja) Mek阻害剤の製造方法
EP0071399A2 (de) Substituierte Pyrrolidin-Cardiogefässsystem-Regulatoren und blutdrucksenkende Mittel, ihre Herstellung und Verwendung
US5026863A (en) 1,4-dihydropyridine compounds
US4672071A (en) Antihypertensive dihydropyridine compositions, optical isomers and intermediates
OHNO et al. Synthesis of asymmetric 4-aryl-1, 4-dihydro-2, 6-dimethyl-3, 5-pyridinedicarboxylates with vasodilating and antihypertensive activities
KR101063146B1 (ko) 피타바스타틴 중간체의 제조방법 및 이를 이용한 피타바스타틴 헤미 칼슘염의 제조방법
US4595690A (en) Antihypertensive dihydropyridine derivatives
JPS6341460A (ja) 新規なジヒドロピリジン誘導体
NO166177B (no) Analogifremgangsmaate til fremstilling av aminometyl-5,6,7,8-tetrahydronaftyloksyeddiksyrer.
JPH0372623B2 (de)
JP3100444B2 (ja) 1,4−ジヒドロピリジン誘導体及びその製造方法
CA1209142A (fr) Procede d'obtention de nouvelles cyanoguanidines et des compositions pharmaceutiques en renfermant
US6448269B1 (en) Glycoprotein IIb/IIIa antagonists
JP3757454B2 (ja) α位に不斉炭素を有するカルボン酸の光学分割方法
TWI746110B (zh) 氧氮雜卓類化合物的製備方法
KR101058530B1 (ko) 고혈압 치료제인 파네실아세톤 유도체의 제조방법 및 이의 중간체
RU2155752C2 (ru) Способы получения производных 1,4-дигидропиридин-3,5-дикарбоновой кислоты в виде r-изомеров и их солей, исходные и промежуточные продукты для их получения
JPH0534351B2 (de)